Home » Topics » BioWorld Science

BioWorld Science
RSS

Celgene launches Istodax in Japan

April 24, 2018

Malaria vaccine R-21 shows efficacy in a phase IIa trial

April 24, 2018

FDA grants fast track designation to AAV-RPGR

April 24, 2018

Atozet launched in Japan

April 24, 2018

Novel selective estrogen receptor degrader LX-039 selected for clinical development

April 24, 2018

AstraZeneca reports data from ARCTIC study of Imfinzi and tremelimumab in third-line NSCLC

April 24, 2018

Researchers present potent EGFR T790M-mutant inhibitor E-191

April 24, 2018

FDA issues partial clinical hold for tazemetostat trials

April 24, 2018

Q Therapeutics and Reprocell create joint venture

April 24, 2018

EMA validates type II variation for Keytruda with pemetrexed and chemotherapy in NSCLC

April 24, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...